LY2062430
LY2062430 Uses, Dosage, Side Effects, Food Interaction and all others data.
LY2062430 is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.
Trade Name | LY2062430 |
Generic | Solanezumab |
Solanezumab Other Names | LY2062430, Solanezumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here LY2062430